GlassScriptPhysician profile
Charles L Cole
NPI 1023012861
$2,073.97
in general payments reported to CMS, 2019-2025
18 companies · $546 in 2025
The $546 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $773 · 2020: $182 · 2021: $63.53 · 2022: $136 · 2023: $282 · 2024: $91.22 · 2025: $546.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $919.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $919.40 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cook Medical LLC | $307.58 | 2019 | |
| Smith+Nephew, INC. | $298.26 | 2020-2025 | Stravix Pl, Oasis, Grafix Pl |
| Pacira Therapeutics, INC. | $226.86 | 2019-2020 | |
| Ethicon US, LLC | $175.78 | 2023-2025 | Surgicel Nu-Knit, Echelon Flex, Enseal |
| Innovation Technologies INC | $155.90 | 2025 | Irrisept |
| Acumed LLC | $140.18 | 2023 | Acumed |
| Pfizer INC. | $131.31 | 2019 | |
| Stryker Corporation | $118.33 | 2025 | Gamma |
| Haemonetics Corporation | $94.65 | 2022 | |
| Integra Lifesciences Corporation | $87.06 | 2021-2022 | |
| Otsuka America Pharmaceutical, INC. | $84.23 | 2024-2025 | Rexulti |
| Zimmer Biomet Holdings, INC. | $62.93 | 2019 | |
| Ferring Pharmaceuticals INC. | $50.23 | 2019-2023 | Euflexxa |
| Depuy Synthes Sales INC. | $46.48 | 2019-2023 | Monovisc, Orthovisc |
| Bioventus LLC | $39.96 | 2019-2024 | Durolane |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sanofi-Aventis U.S. LLC | $22.71 | 2020 | |
| Djo, LLC | $17.65 | 2022 | |
| Molnlycke Health Care US, LLC | $13.87 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Charles Cole listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.